An example is provided by Griswold et al32 in 2021, suggesting that African compared with European ancestry haplotypes on APOE*4 reduced expression of APOE*4, which in turn may explain attenuated effect sizes for APOE*44 and AD risk in individuals of African ancestry compared with those of European ancestry. The gene discussed is APOE; the disease is Alzheimer disease.